Serge Saxonov - 29 May 2025 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role
Chief Executive Officer, Director
Signature
/s/ Eric S. Whitaker, as Attorney-in-Fact for Serge Saxonov
Issuer symbol
TXG
Transactions as of
29 May 2025
Transactions value $
$0
Form type
4
Filing time
02 Jun 2025, 17:16:35 UTC
Previous filing
27 May 2025
Next filing
11 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Saxonov Serge Chief Executive Officer, Director 10X GENOMICS, INC., 6230 STONERIDGE MALL ROAD, PLEASANTON /s/ Eric S. Whitaker, as Attorney-in-Fact for Serge Saxonov 02 Jun 2025 0001786720

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXG Class A Common Stock Gift $0 -3K -0.28% $0.00 1.08M 29 May 2025 Direct
holding TXG Class A Common Stock 27 29 May 2025 See footnote F1
holding TXG Class A Common Stock 870 29 May 2025 See footnote F2
holding TXG Class A Common Stock 213K 29 May 2025 See footnote F3
holding TXG Class A Common Stock 22.6K 29 May 2025 See footnote F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are held by the Andromeda Trust, for which the Reporting Person serves as trustee.
F2 The shares are held by the Sirius Trust, for which the Reporting Person serves as trustee.
F3 The shares are held by the Y/S Descendants' Trust, for which the Reporting Person serves as trustee.
F4 The shares are held by the Y/S Pot Trust, for which the Reporting Person serves as trustee.